ATF2 Interacts with β-Cell-enriched Transcription Factors, MafA, Pdx1, and Beta2, and Activates Insulin Gene Transcription

被引:31
|
作者
Han, Song-iee [1 ]
Yasuda, Kunio [1 ]
Kataoka, Kohsuke [1 ]
机构
[1] Nara Inst Sci & Technol, Mol & Dev Biol Lab, Grad Sch Biol Sci, Ikoma 6300192, Japan
基金
日本学术振兴会;
关键词
N-TERMINAL KINASE; KEY REGULATOR; GLUCOSE; PROMOTER; EXPRESSION; PHOSPHORYLATION; DIFFERENTIATION; PROTEINS; GLUCAGON; INHIBIT;
D O I
10.1074/jbc.M110.209510
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pancreatic beta-cell-restricted expression of insulin is established through several critical cis-regulatory elements located in the insulin gene promoter region. The principal cis elements are A-boxes, E1, and C1/RIPE3b. The beta-cell-enriched transcription factors Pdx1 and Beta2 bind to the A-boxes and E1 element, respectively. A beta-cell-specific trans-acting factor binding to C1/RIPE3b (termed RIPE3b1 activator) was detected by electrophoretic mobility shift assay and has been identified as MafA, a member of the Maf family of basic leucine zipper (bZip) proteins. Here, ATF2, a member of the ATF/CREB family of basic leucine zipper proteins, was identified as a component of the RIPE3b1 activator. ATF2 alone was unable to bind to the C1/RIPE3b element but acquired binding capacity upon complex formation with MafA. ATF2 also interacted with Pdx1 and Beta2, and co-expression of ATF2, MafA, Pdx1, and Beta2 resulted in a synergistic activation of the insulin promoter. Immunohistochemical analysis of mouse pancreas tissue sections showed that ATF2 is enriched in islet endocrine cells, including beta-cells. RNAi-mediated knockdown of MafA or ATF2 in the MIN6 beta-cell line resulted in a significant decrease in endogenous levels of insulin mRNA. These data indicate that ATF2 is an essential component of the positive regulators of the insulin gene expression.
引用
收藏
页码:10449 / 10456
页数:8
相关论文
共 50 条
  • [1] Synergistic activation of the insulin gene promoter by the β-cell enriched transcription factors MafA, Beta2, and Pdx1
    Aramata, S
    Han, S
    Yasuda, K
    Kataoka, K
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2005, 1730 (01): : 41 - 46
  • [2] Transcription factor BETA2 acts cooperatively with E2A and PDX1 to activate the insulin gene promoter
    Glick, E
    Leshkowitz, D
    Walker, MD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (03) : 2199 - 2204
  • [3] The islet β cell-enriched MafA activator is a key regulator of insulin gene transcription
    Zhao, L
    Guo, M
    Matsuoka, TA
    Hagman, DK
    Parazzoli, SD
    Poitout, V
    Stein, R
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (12) : 11887 - 11894
  • [4] Generation of Insulin Expressing Cells in Mouse Small Intestine by Pdx1, MafA, and BETA2/NeuroD
    Hyun, Lee So
    Kim, Jiwon
    Yoon, Kun-Ho
    DIABETES, 2018, 67
  • [5] Generation of Insulin-Expressing Cells in Mouse Small Intestine by Pdx1, MafA, and BETA2/NeuroD
    Lee, So-Hyun
    Rhee, Marie
    Kim, Ji-Won
    Yoon, Kun-Ho
    DIABETES & METABOLISM JOURNAL, 2017, 41 (05) : 405 - 414
  • [6] PDX1, Neurogenin-3, and MAFA: critical transcription regulators for beta cell development and regeneration
    Yaxi Zhu
    Qian Liu
    Zhiguang Zhou
    Yasuhiro Ikeda
    Stem Cell Research & Therapy, 8
  • [7] PDX1, Neurogenin-3, and MAFA: critical transcription regulators for beta cell development and regeneration
    Zhu, Yaxi
    Liu, Qian
    Zhou, Zhiguang
    Ikeda, Yasuhiro
    STEM CELL RESEARCH & THERAPY, 2017, 8
  • [9] Ectopic expression of the beta-cell specific transcription factor Pdx1 inhibits glucagon gene transcription
    Ritz-Laser, B
    Gauthier, BR
    Estreicher, A
    Mamin, A
    Brun, T
    Ris, F
    Salmon, P
    Halban, PA
    Trono, D
    Philippe, J
    DIABETOLOGIA, 2003, 46 (06) : 810 - 821
  • [10] Ectopic expression of the beta-cell specific transcription factor Pdx1 inhibits glucagon gene transcription
    B. Ritz-Laser
    B. R. Gauthier
    A. Estreicher
    A. Mamin
    T. Brun
    F. Ris
    P. Salmon
    P. A. Halban
    D. Trono
    J. Philippe
    Diabetologia, 2003, 46 : 810 - 821